Taken together, these data showed that it was the activation of the GLP‐1 receptor with Ex‐4 or the elevation of endogenous GLP‐1 with saxagliptin rather than insulin that alleviated cardiac injury in DM. This evidence concerns the gene INS and diabetes mellitus.